Trial Profile
Adenovirus Vaccine Pregnancy Registry
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase IV
Latest Information Update: 02 Nov 2021
Price :
$35
*
At a glance
- Drugs DR 5001 (Primary)
- Indications Adenovirus infections
- Focus Therapeutic Use
- Sponsors Teva Branded Pharmaceutical Products R&D
- 18 Apr 2014 Status changed from recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 30 Apr 2012 New trial record